TSX-V Symbol "ERG"
MONTREAL, July 30 /CNW Telbec/ - The board of directors of Ergoresearch ltee. ("Ergoresearch") (TSX Venture Exchange: ERG) has authorized on July 30, 2008 the grant of stock options in favour of five of its officers in accordance with the stock option plan.
According to the resolutions adopted, the 500 000 stock options granted, were allocated as follows:
Mr Francois Tellier, Director, 100,000 options
Mr Bryan Godbout, Director : 100 000 options
Mr Michel Pierron, Director : 100 000 options
Mrs Danielle Boucher, officer: 100 000 options
Mr Sylvain Boucher, President and CEO : 100 000 options
The exercise price of all the options was fixed at $0.10 per share. Ergoresearch'closing price, on July 29, 2008 was $0,10 / share. These options can be exercised up until July 30, 2013.
A total of 2 980 313 stock options were made available in regard of the company's stock option plan. The total amount currently granted to Directors and key employees is now at 785 000 stock option (average exercisable price of 0.10$ per share), thus leaving 2 195 313 undistributed stock option.
Ergoresearch Ltd. is a leading Canadian manufacturer of orthotics and a state-of-the-art designer of durable medical equipment for the orthopedics market. The company, now vertically integrated has the ambition of becoming an international leader in the orthopedic industry.
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.